| |
| |
|
| Insider
Information: |
Fox Jonathan C |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
10,857 |
|
|
Indirect Shares
|
377,673 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$46,155,417 |
|
|
| Total
Shares |
388,530 |
|
|
| Total
Value |
$46,155,417 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 156.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eidos Therapeutics, Inc. |
EIDX |
See Remarks |
2021-01-26 |
0 |
2020-09-17 |
377,673 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
|
2023-12-26 |
10,857 |
2023-12-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EWTX |
Edgewise Therapeutics, In... |
|
– • – |
2023-12-26 |
4 |
B |
$9.30 |
$100,958 |
D/D |
10,857 |
10,857 |
0.01 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2021-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(380,467) |
0 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
380,467 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-09-17 |
4 |
AS |
$50.16 |
$289,259 |
I/I |
(5,767) |
377,673 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-09-16 |
4 |
AS |
$50.16 |
$156,610 |
I/I |
(3,122) |
383,440 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-09-15 |
4 |
AS |
$50.06 |
$50,064 |
I/I |
(1,000) |
386,562 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-09-14 |
4 |
AS |
$50.00 |
$5,550 |
I/I |
(111) |
387,562 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-07-07 |
4 |
AS |
$50.00 |
$250,000 |
I/I |
(5,000) |
387,673 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,088 |
392,673 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-06-03 |
4 |
AS |
$50.00 |
$250,000 |
I/I |
(5,000) |
391,585 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-06-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,020 |
396,585 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-06-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,020 |
397,605 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-05-31 |
4 |
A |
$41.57 |
$18,459 |
D/D |
444 |
3,294 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-05-28 |
4 |
AS |
$50.00 |
$250,000 |
I/I |
(5,000) |
398,625 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-04-24 |
4 |
AS |
$50.00 |
$107,650 |
I/I |
(2,153) |
403,625 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-04-23 |
4 |
AS |
$50.00 |
$142,350 |
I/I |
(2,847) |
405,778 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-03-02 |
4 |
S |
$51.57 |
$515,706 |
I/I |
(10,000) |
408,625 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-02-13 |
4 |
S |
$54.00 |
$540,000 |
I/I |
(10,000) |
418,625 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-02-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,632 |
428,625 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-01-15 |
4 |
S |
$55.00 |
$196,900 |
I/I |
(3,580) |
430,257 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2020-01-14 |
4 |
S |
$55.01 |
$353,172 |
I/I |
(6,420) |
433,837 |
0 |
% |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2019-12-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
100 |
440,257 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2019-12-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
170 |
440,357 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2019-12-04 |
4 |
S |
$58.90 |
$589,048 |
I/I |
(10,000) |
440,527 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
See Remarks |
• – – |
2019-11-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
450,527 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
